Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A mouse model for cystinuria type I.

T Peters1, C Thaete, S Wolf

  • 1Ingenium Pharmaceuticals AG, Fraunhoferstr. 13, 82152 Martinsried, Germany.

Human Molecular Genetics
|August 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Food system development pathways for healthy, nature-positive and inclusive food systems.

Nature food·2023
Same author

Optical pumping of quantum dot micropillar lasers.

Optics express·2021
Same author

Characterizing Adversity of Lysosomal Accumulation in Nonclinical Toxicity Studies: Results from the 5th ESTP International Expert Workshop.

Toxicologic pathology·2018
Same author

Artificial urine and FBS supplemented media in cytocompatibility assays for PLGA-PEG-based intravesical devices using the urothelium cell line UROtsa.

Journal of biomedical materials research. Part B, Applied biomaterials·2017
Same author

Diazepam actions in the VTA enhance social dominance and mitochondrial function in the nucleus accumbens by activation of dopamine D1 receptors.

Molecular psychiatry·2017
Same author

Immune and autoimmune gluten-related phenomenon in systemic lupus erythematosus.

Lupus·2017
Same journal

Nucleic acid-based therapeutic strategies for modulator-refractory cystic fibrosis-causing variants.

Human molecular genetics·2026
Same journal

Evidence that disruption of Discoidin domain receptor 2 contributes to palate malformations through effects on the extracellular matrix.

Human molecular genetics·2026
Same journal

Nicotinamide riboside prevents mitochondrial dysfunction in nemaline myopathy type 6.

Human molecular genetics·2026
Same journal

Retraction: Aqua-soluble DDQ reduces the levels of Dr1 and Ab and inhibits abnormal interactions between Ab and Dr1 and protects Alzheimer's disease neurons from Ab- and Dr1-induced mitochondrial and synaptic toxicities.

Human molecular genetics·2026
Same journal

Retraction: Breast cancer cell-derived exosome-delivered microRNA-155 targets UBQLN1 in adipocytes and facilitates cancer cachexia-related fat loss.

Human molecular genetics·2026
Same journal

Editor's Note: Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease.

Human molecular genetics·2026
See all related articles

Researchers developed a new mouse model for cystinuria, a metabolic disorder causing kidney stones. This model accurately replicates human cystinuria type I, aiding in understanding the disease and testing treatments.

Area of Science:

  • Genetics and Molecular Biology
  • Nephrology and Urology
  • Inborn Errors of Metabolism

Background:

  • Cystinuria is a common inherited metabolic disorder affecting 1-2% of renal lithiasis cases.
  • It results from defects in the rBAT/b0,+AT transporter, impairing renal and intestinal reabsorption of cystine and basic amino acids.
  • Current understanding of cystinuria pathophysiology and treatment evaluation is limited by the lack of suitable animal models.

Purpose of the Study:

  • To identify and characterize a novel mouse model for cystinuria.
  • To investigate the genetic basis of the identified mutation.
  • To evaluate the utility of this mouse model for studying cystinuria and testing therapeutic strategies.

Main Methods:

  • An N-ethyl-N-nitrosourea mutagenesis screen was employed to identify recessive mutations.

Related Experiment Videos

  • Phenotypic analysis included urine amino acid profiling and assessment of urolithiasis.
  • Positional cloning was used to identify the causative gene and specific mutation.

    • Main Results:

    • A mutant mouse exhibiting elevated urinary lysine, arginine, and ornithine was identified.
    • The mouse displayed clinical signs of urolithiasis and complications.
    • A missense mutation (D140G) in the solute carrier family 3 member 1 gene (Slc3a1) was identified as the causative mutation in the rBAT protein.

    Conclusions:

    • The identified Slc3a1 mutation results in a mouse model that faithfully mimics human cystinuria type I.
    • This novel mouse model is valuable for elucidating cystinuria pathophysiology.
    • The model provides a platform for evaluating potential therapeutic and metaphylactic interventions for cystinuria.